HR NEWS

New painkillers reduce overdose risk

New painkillers reduce overdose risk

Scientists have developed new opioid pain relievers that reduce pain on par with morphine and do not slow or stop breathing caused by overdose.  According to the US Centers for Disease Control and Prevention, 91 Americans die every day from opioid overdoses – deaths caused when opiates like oxycontin, heroin and fentanyl slow and eventually stop a person’s breathing.  The research shows that a range of compounds can deliver pain-blocking potency without affecting respiration, said Laura M Bohn, Professor at The Scripps Research Institute (TSRI) in the US.

The study builds on two decades of research which questioned whether the painkilling pathway, called the G protein pathway, could beunlinked from the breathing suppression pathway, called the beta-arrestin pathway.  “One of the questions we had was how good we can get at separating out the pathways, and how much separation do we need to see analgesia without respiratory suppression,” said Bohn, who led the study published in the journal Cell.  Researchers developed new potential drug molecules; they then tweaked their chemical structures to systematically vary the “bias” between the two pathways – G protein signalling and beta-arrestin recruitment.

They developed more than 500 compounds in the past six years, and found more than 60 that showed bias between signalling assays.  The researchers then selected six compounds to represent a wide range in the degree of bias (from those that preferred barrestin recruitment to those that almost exclusively preferred G protein signalling) and determined their overall potency for inducing analgesia and respiratory suppression in mouse models. They found that the new compounds could indeed enter the brain – and all of the compounds were as potent, if not more, than morphine.

The compounds that were less able to promote barrestin associations in cells were also less likely to induce respiratory suppression in mice.
In contrast, the painkiller fentanyl was shown to prefer receptor-barrestin associations and also had a more narrow safety margin.

6 months ago

By HR Reporters


Social Share : Share      

Comments.....

Submit new comment

Most Viewed

Air India unauthorised payment scam: Chief Vigilance Officer Shobha Ohatker unde...

10 months ago

Uber hires legal chief Tony West from Pepsi amid mounting pressure...

8 months ago

Prosecutors appeal against ruling on Samsung heir...

10 months ago

Railways can create 1 million jobs; global tender soon for tracks...

8 months ago

Snapdeal CFO Anup Vikal quits; acquisition talks with Flipkart collapse...

8 months ago

Ketamine may reduce suicidal thoughts, says study...

6 months ago

Carfilzomib may up risk of cardiovascular problems: Study...

5 months ago

This company spent $6m to close gender pay gap...

8 months ago

Arundhati Bhattacharya – Captain Courageous: SBI chairman weathered NPA storm an...

8 months ago

FE Best Bank Awards - 2017 Declared...

6 months ago

Most Shared

Mass redundancies for Quebec cookie factory...

2 years ago

Trump this: 5 bold predictions for how he’ll impact HR...

2 years ago

InfoTycoon appoints existing President and COO Kevin George to succeed James Dav...

2 years ago

Sushant Dwivedy joins Aspiring Minds as SVP-Enterprise Client Solutions...

2 years ago

Uber introduces special reward programme...

2 years ago

Standard Chartered Bank to reduce 10% corporate & institutional banking staff...

2 years ago

National CineMedia (NCM) creates Affiliate Partnerships team, names Stacie Tursi...

2 years ago

OCC Names New CFO, Treasurer, and Chief Compliance Officer...

2 years ago

Beards at work are now a major turn-off say 61% of female office workers...

2 years ago

First female fast jet pilot of Britain hired as director at PwC...

2 years ago